2012
DOI: 10.1123/jab.28.2.184
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological Treatment of Intermittent Claudication Does Not Have a Significant Effect on Gait Impairments During Claudication Pain

Abstract: Peripheral arterial disease (PAD) is a manifestation of atherosclerosis resulting in intermittent claudication (IC) or leg pain during physical activity. Two drugs (cilostazol and pentoxifylline) are approved for treatment of IC. Our previous work has reported no significant differences in gait biomechanics before and after drug interventions when PAD patients walked without pain. However, it is possible that the drugs are more efficacious during gait with pain. Our aim was to use advanced biomechanical analys… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 51 publications
(66 reference statements)
0
4
0
Order By: Relevance
“…Precise assessment of gait biomechanics has proven a useful way to assess differences versus healthy counterparts, determine mechanisms responsible for gait alterations, and evaluate treatment effectiveness in patients with PAD. 5658 Therefore, determining the presence of PAD without the need to induce leg pain will be beneficial for assessing the risk of disease progression and allow early interventions and therapies to prevent or lessen the consequences of the disease. A recent study successfully implemented a machine learning model on gait biomechanics data to identify presence of PAD.…”
Section: Discussionmentioning
confidence: 99%
“…Precise assessment of gait biomechanics has proven a useful way to assess differences versus healthy counterparts, determine mechanisms responsible for gait alterations, and evaluate treatment effectiveness in patients with PAD. 5658 Therefore, determining the presence of PAD without the need to induce leg pain will be beneficial for assessing the risk of disease progression and allow early interventions and therapies to prevent or lessen the consequences of the disease. A recent study successfully implemented a machine learning model on gait biomechanics data to identify presence of PAD.…”
Section: Discussionmentioning
confidence: 99%
“…For example, the introduction of moderate-intensity walking training may lead to an increase in the distance covered by patients [34, 35]. Pharmacological treatment of IC does not have a significant effect on gait impairments [36, 37]. A number of reviews have reported the influence of exercise therapy for the treatment of patients with IC [25, 3845].…”
Section: Discussionmentioning
confidence: 99%
“…One promising approach concerns the intermittent pneumatic compression (IPC), which determines an improvement in walking distance without claudication and the ABI after exercise [59]. Classically, this type of treatment is used in the phlebologic therapy for the treatment of venous leg ulcers, prophylaxis of deep vein thrombosis, while in lymphology it is used for the treatment of lymphedema [60][61][62].…”
Section: New (Stem Cell and Gene Therapy) And Alternative Therapiesmentioning
confidence: 99%